Presented by: Michael A. Spinner, MD, Clinical Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD CAR T-cell therapy in hematologic malignancies has more options than ever before,
Presented by: Michael A. Spinner, MD, Clinical Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD CAR T-cell therapy in hematologic malignancies has more options than ever before,
MorePresented by: Julia Carnevale, MD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD “Solid tumors are the next big frontier for cell therapies,” describes Dr. Julia Carnevale,
More